Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
 
Register | Sign in
Home Page>Products
  Product News
Avacta Extends Optim® 2 Product Family for Even Greater Measurement Flexibility
Thursday, October 09, 2014
An innovative analytical instrument designed to probe multiple protein stability.

FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.

Bosch Spotlights Complete Packaging Systems Competence
Wednesday, October 08, 2014
Single-source solutions provider for entry-level through high-end technologies.

Phenomenex Introduces First Synthetic Sorbent for SLE
Wednesday, October 08, 2014
Novum Simplified Liquid Extraction - Ideal for the cleanup of biological samples.

New Comparator Balances from Mettler Toledo
Wednesday, October 08, 2014
Increased pressure on calibration laboratories to comply with industry regulations, such as United States Pharmacopeia (USP) Chapter 41 and Good Manufacturing Practice, have led to a growing demand for weight calibration.

Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A
Wednesday, October 08, 2014
Optimized kit for use with Gyros immunoassay platform.

ARTES, InstrAction and Q-Biologicals Join Forces
Tuesday, October 07, 2014
Three-party consortium for vaccine developments for veterinary applications.

New Methodology for CHN Determination of Liquid Samples
Tuesday, October 07, 2014
Exeter Analytical’s application note demonstrates the utility of Model 440 CHN microanalysis system.

New Compact SIMS - Mass Spectrometry in Solid Material
Saturday, October 04, 2014
Designed for fast and easy characterization of layer structures, surface contamination and impurities.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 10576
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv